Covid-19 roundup: Moderna vaccine kicks up antibodies against Delta variant; UK study validates mix-and-match approach for Pfizer-AstraZeneca

Jason Mast

Editor

Amber Tong

In an continued effort to monitor the effectiveness of its Covid-19 vaccine, Moderna has rolled out the latest slate of neutralization data against different variants …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: Moderna vaccine kicks up antibodies against Delta variant; UK study validates mix-and-match approach for Pfizer-AstraZeneca

Jason Mast

Editor

Amber Tong

Sign up to read this article for free.

RFK Jr. and Elon Musk want to ban pharma ads. They wouldn't be the first to try

Jazz wins approval for bispecific in biliary tract cancer

Novartis seeks more bolt-on deals as it purchases neuro startup for up to $1.1B

FDA adcomm raises risk questions on AstraZeneca’s Andexxa

At Jefferies, all that manufacturers want to talk about is GLP-1s

Are programs with compounded GLP-1s safe for your population?

Covid-19 roundup: Mod­er­na vac­cine kicks up an­ti­bod­ies against Delta vari­ant; UK study val­i­dates mix-and-match ap­proach for Pfiz­er-As­traZeneca

Editor

Sign up to read this article for free.

Covid-19 roundup: Moderna vaccine kicks up antibodies against Delta variant; UK study validates mix-and-match approach for Pfizer-AstraZeneca